nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AML: making residual disease more measurable
|
Voso, Maria Teresa |
|
|
140 |
5 |
p. 415-417 |
artikel |
2 |
An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study
|
Li, Si-Qi |
|
|
140 |
5 |
p. 516-520 |
artikel |
3 |
CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR
|
Shalabi, Haneen |
|
|
140 |
5 |
p. 451-463 |
artikel |
4 |
CLL and COVID-19: light at the end of the tunnel?
|
Scarfò, Lydia |
|
|
140 |
5 |
p. 407-409 |
artikel |
5 |
COVID monoclonal antibody therapy detected by serum immunofixation electrophoresis
|
Shaver, Aaron C. |
|
|
140 |
5 |
p. 521 |
artikel |
6 |
Editorial Board
|
|
|
|
140 |
5 |
p. i |
artikel |
7 |
How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge
|
Akwaa, Frank |
|
|
140 |
5 |
p. 438-444 |
artikel |
8 |
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
|
Niemann, Carsten U. |
|
|
140 |
5 |
p. 445-450 |
artikel |
9 |
p57Kip2 indirectly regulates AGM HSCs
|
Mao, Xinjian |
|
|
140 |
5 |
p. 411-412 |
artikel |
10 |
p57Kip2 regulates embryonic blood stem cells by controlling sympathoadrenal progenitor expansion
|
Kapeni, Chrysa |
|
|
140 |
5 |
p. 464-477 |
artikel |
11 |
Platelets get particular
|
Rauova, Lubica |
|
|
140 |
5 |
p. 413-414 |
artikel |
12 |
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC
|
Olsen, Elise A. |
|
|
140 |
5 |
p. 419-437 |
artikel |
13 |
Reverse translational studies inform dual-targeted CAR T-cell design
|
Rouce, Rayne H. |
|
|
140 |
5 |
p. 409-410 |
artikel |
14 |
Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma
|
Cherng, Hua-Jay J. |
|
|
140 |
5 |
p. 504-515 |
artikel |
15 |
Thrombocytopenia and splenic platelet-directed immune responses after IV ChAdOx1 nCov-19 administration
|
Nicolai, Leo |
|
|
140 |
5 |
p. 478-490 |
artikel |
16 |
Tumor-intrinsic causes of CAR-T failure
|
Heslop, Helen E. |
|
|
140 |
5 |
p. 414-415 |
artikel |
17 |
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma
|
Jain, Michael D. |
|
|
140 |
5 |
p. 491-503 |
artikel |